These self-administered questions ask about different cancer screening tests a respondent may have had in the past 3 years. The protocol includes the following screenings: mammogram, pap smear, pelvic examination, Prostate Specific Antigen (PSA) test, colonoscopy, ultrasound of the ovaries, barium enema, chest x-ray, sigmoidoscopy, and digital rectal examination. All respondents are asked questions 1-3. Only female respondents are asked questions 4-8, and only male respondents are asked questions 9 and 10. While not currently performed as part of routine cancer screening, the Working Group recommends including questions about two additional cancer screening procedures: Helical computed tomography (CT) scan and whole body scan.
status
ACTIVE
Fully-Specified Name
component
PhenX - cancer screenings protocol 070901
property
-
time
Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.
Release 2.81: Status: Changing PhenX Concept from Status = Trial to Active; Previous Releases: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Quick, Current, Complete - www.findacode.com